Skip to main content

Hypophosphatemic Rickets clinical trials at UCSF
1 research study open to eligible people

  • X-linked Hypophosphatemia Disease Monitoring Program

    open to all eligible people

    The objectives of this observational study are to characterize XLH disease presentation and progression and to assess long-term effectiveness and safety of burosumab.

    San Francisco, California and other locations

Last updated: